DI
BEAM icon

Disciplined Investments’s Beam Therapeutics BEAM Stock Holding History

Disciplined Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-104
Closed -$5K – 1647
2022
Q3 		$5K Hold
104
– – ﹤0.01% 426
2022
Q2 		$4K Hold
104
– – ﹤0.01% 467
2022
Q1 		$6K Hold
104
– – ﹤0.01% 425
2021
Q4 		$8K Buy
+104
New +$8.9K ﹤0.01% 358

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Disciplined Investments's BEAM Position: Q4 2022 in Review

Disciplined Investments sold out of Beam Therapeutics (BEAM) in Q4 2022, closing a stake of 104 shares — an estimated $5K sold.

Disciplined Investments first reported a position in BEAM in Q4 2021 and held it in 4 quarters. The position peaked at $8K in Q4 2021. 207 funds tracked by Wall St. Rank hold BEAM as of Q4 2022.

  • Disciplined Investments reported no remaining Beam Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Disciplined Investments sold 104 Beam Therapeutics shares in Q4 2022, an estimated $5K.
  • Disciplined Investments first reported a position in Beam Therapeutics in Q4 2021 and held it in 4 quarters.
  • Disciplined Investments's Beam Therapeutics position peaked at $8K in Q4 2021.
  • 207 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2022.

Based on Disciplined Investments's 13F filing for Q4 2022, filed 2 Feb 2023.